Get started
Cel-Sci CorporationCel-Sci CorporationCel-Sci Corporation

Cel-Sci Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

CVM chart


Full chart

CVM upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪44.54 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.5671 USD
Net income (FY)
‪−32.19 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪62.00 M‬
Beta (1Y)
0.16

About Cel-Sci Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Geert R. Kersten
Website
cel-sci.com
Headquarters
Vienna
Founded
1983
FIGI
BBG000H5G6L5
CEL-SCI Corp. is a biotechnology company, which engages in the research, development and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CVM news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CVM is 0.7000 USD — it has decreased by −4.37% in the past 24 hours. Watch Cel-Sci Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Cel-Sci Corporation stocks are traded under the ticker CVM.
CVM stock has risen by 1.16% compared to the previous week, the month change is a 15.47% rise, over the last year Cel-Sci Corporation has showed a −74.73% decrease.
We've gathered analysts' opinions on Cel-Sci Corporation future price: according to them, CVM price has a max estimate of 6.20 USD and a min estimate of 6.20 USD. Watch CVM chart and read a more detailed Cel-Sci Corporation stock forecast: see what analysts think of Cel-Sci Corporation and suggest that you do with its stocks.
CVM reached its all-time high on May 23, 1986 with the price of 21,406.2500 USD, and its all-time low was 0.4947 USD and was reached on Dec 6, 2024. View more price dynamics on CVM chart.
See other stocks reaching their highest and lowest prices.
CVM stock is 3.85% volatile and has beta coefficient of 0.16. Track Cel-Sci Corporation stock price on the chart and check out the list of the most volatile stocks — is Cel-Sci Corporation there?
Today Cel-Sci Corporation has the market capitalization of ‪44.54 M‬, it has increased by 13.82% over the last week.
Yes, you can track Cel-Sci Corporation financials in yearly and quarterly reports right on TradingView.
Cel-Sci Corporation is going to release the next earnings report on Dec 24, 2024. Keep track of upcoming events with our Earnings Calendar.
CVM earnings for the last quarter are −0.14 USD per share, whereas the estimation was −0.12 USD resulting in a −16.67% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Cel-Sci Corporation earnings.
CVM net income for the last quarter is ‪−6.86 M‬ USD, while the quarter before that showed ‪−7.24 M‬ USD of net income which accounts for 5.36% change. Track more Cel-Sci Corporation financial stats to get the full picture.
No, CVM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CVM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cel-Sci Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cel-Sci Corporation technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cel-Sci Corporation stock shows the sell signal. See more of Cel-Sci Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.